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The facultative intracellular pathogen Bartonella
henselae is responsible for a broad range of clinical man-
ifestations, including the formation of vascular tumors as
a result of increased proliferation and survival of colo-
nized endothelial cells. This remarkable interaction with
endotoxin-sensitive endothelial cells and the apparent
lack of septic shock are considered to be due to a reduced
endotoxic activity of the B. henselae lipopolysaccharide.
Here, we show that B. henselae ATCC 49882T produces a
deep-rough-type lipopolysaccharide devoid of O-chain
andreportonitscompletestructureandToll-likereceptor-
dependent biological activity. The major short-chain li-
popolysaccharide was studied by chemical analyses, elec-
trospray ionization, and matrix-assisted laser desorption/
ionization mass spectrometry, as well as by NMR
spectroscopy after alkaline deacylation. The carbohy-
drate portion of the lipopolysaccharide consists of a
branched trisaccharide containing a glucose residue at-
tached to position 5 of an -(234)-linked 3-deoxy-D-
manno-oct-2-ulosonic acid disaccharide. Lipid A is a
pentaacylated -(136)-linked 2,3-diamino-2,3-dideoxy-
glucose disaccharide 1,4-bisphosphate with two amide-
linked residues each of 3-hydroxydodecanoic and 3-hy-
droxyhexadecanoic acids and one residue of either 25-
hydroxyhexacosanoic or 27-hydroxyoctacosanoic acid
that is O-linked to the acyl group at position 2. The li-
popolysaccharide studied activated Toll-like receptor 4
signaling only to a low extent (1,000–10,000-fold lower
compared with that of Salmonella enterica sv. Friedenau)
and did not activate Toll-like receptor 2. Some unusual
structural features of the B. henselae lipopolysaccharide,
including the presence of a long-chain fatty acid, which
are shared by the lipopolysaccharides of other bacteria
causing chronic intracellular infections (e.g. Legionella
and Chlamydia), may provide the molecular basis for low
endotoxic potency.
Bartonella henselae is an emerging zoonotic pathogen. In the
feline reservoir host this cat flea-borne Gram-negative patho-
gen causes a long lasting intraerythrocytic bacteremia associ-
ated with little or no symptoms of disease (1). B. henselae is
transmitted to humans by cat scratch or bite or the bite of an
infected cat flea. Human infection results in a broad range of
clinical manifestations, which often have a chronic course. Cat-
scratch disease is a necrotizing inflammatory lymphadenitis
typically associated with fever, which represents the most com-
mon disease manifestation in immunocompetent patients. Pro-
longed febrile bacteremic syndrome is a frequent disease man-
ifestation of immunocompromized patients, which, unlike
bacteremia by most other Gram-negative bacteria, has never
been reported to result in septic shock. Bacillary angiomatosis
and bacillary peliosis are angioproliferative lesions also found
primarily in immunocompromised hosts (2).
Angioproliferation stimulated by B. henselae is a remarkable
pathogenic process which represents a unique model to study
pathogen-triggered tumor formation. Judged from the histol-
ogy of bacillary angiomatosis and bacillary peliosis lesions,
bacteria are in direct contact with the endothelium, probably
triggering both endothelial cell proliferation and proinflamma-
tory activation. Therefore, endothelial cells appear to represent
a specific and unique target of B. henselae, and a detailed
analysis of the bacteria-endothelial cell interactions is thus
vital for understanding the pathophysiology of this emerging
infection. Human umbilical vein endothelial cells have been
used as an in vitro model to study important steps in the
interaction of B. henselae with endothelial cells. This faculta-
tive intracellular pathogen invades endothelial cells by two
different processes, either (i) by conventional endocytosis of
single bacteria or small bacterial aggregates, which results in
perinuclear-localizing intravacuolar bacteria, or (ii) by the in-
vasion of large bacterial aggregates by a host cell-driven proc-
ess referred to as invasome-mediated internalization (3).
B. henselae is considered to provoke angioproliferation by at
least two independent mechanisms (4): directly, by triggering
proliferation (5) and inhibiting apoptosis of endothelial cells (6)
and indirectly, by stimulating a paracrine angiogenic loop of
vascular endothelial growth factor production by infected
macrophages (7).
The lipopolysaccharides (LPS)1 of Gram-negative bacteria
are known as endotoxins, which cause the prominent patho-
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physiological symptoms associated with sepsis and septic
shock, i.e. fever, leukopenia, hypertension, disseminated intra-
vascular organ failure, and multiple organ failure. The LPS
from enteric bacteria, such as Escherichia coli and Salmonella
enterica, are highly potent molecules with regard to their bio-
logical, i.e. endotoxic activities. The lipid A portion is respon-
sible for these activities of the enterobacterial LPS (8). Endo-
thelial cells sense the endotoxin by soluble CD14 and toll-like
receptor 4 (TLR4), resulting in the nuclear factor B (NF-B)-
dependent activation of a proinflammatory response. This phe-
notype is characterized by the up-regulation of the adhesion
molecules ICAM-1 and E-selectin and the secretion of proin-
flammatory cytokines and chemokines (9).
B. henselae infection of human umbilical vein endothelial
cells results in a prominant NF-B-dependent proinflamma-
tory activation (10, 11). However, this process is triggered by
proteinacious components of the bacteria rather than by LPS
(10). A mutant defective for the bacterial type IV secretion
system VirB was shown to display only minimal activation of
NF-B, suggesting that bacterial effector proteins translocated
by this system into endothelial cells are responsible for the
proinflammatory phenotype observed during infection with
wild-type B. henselae (11). Moreover, in contrast to wild type,
the VirB-defective mutant displayed any noticeable toxic effect
on endothelial cells, even at very high infection doses (11).
Assuming that LPS is not affected in the VirB-defective mu-
tant, the LPS of B. henselae appears to be devoid of toxicity for
endothelial cells (11). This observation together with the ap-
parent absence of septic shock in bacteremic patients indicates
that the LPS of this pathogen is of low endotoxic activity. The
B. henselae LPS should thus be interesting in regard to struc-
ture/function analysis. This LPS is composed of a major rough-
type form (R-form, lacking O-chain), and a minor smooth-type
form (S-form, containing O-chain) (12). However, despite the
presence of a long-chain fatty acid (13), no information is avail-
able regarding the structure of B. henselae LPS and lipid A.
Based on the limited information available, a simliar LPS
is found in the closely related species B. bacilliformis and
B. quintana, which represent the only other known pathogens
capable of triggering angioproliferative lesions in humans. The
B. bacilliformis LPS is also composed of a minor S-form and a
major R-form, the latter being poorly immunogenic in rabbits
(14). Consistently, the B. quintana LPS was described to be
predominantly of a “deep-rough” chemotype (15) and was fur-
ther shown to possess a lower endotoxic activity on whole blood
cells and endothelial cells than typical endotoxins (15, 16).
In this paper, we describe elucidation of the structure of a
short-chain LPS representing the major LPS species from
B. henselae ATCC 49882T. The unusual structural features of
this novel LPS are: (i) pentaacyl lipid A, containing a GlcN3N
disaccharide bisphosphate [4-P--D-GlcpN3N-(136)--D-
GlcpN3N-13P] as the lipid A backbone and a long-chain fatty
acid, namely 26:0(25-OH) or 28:0(27-OH), and (ii) a small and
unique inner core composed of an -(234)-linked 3-deoxy-d-
manno-oct-2-ulosonic acid (Kdo) disaccharide with one glucose
residue attached. Moreover, we demonstrated that this LPS
has a low endotoxic potential as measured by TLR4 signaling
and, in contrast to LPS from some other pathogens, does not
activate TLR2-signaling to any considerable extend. The struc-
ture and biological activity of the B. henselae ATCC 49882T
short-chain LPS displays interesting parallels with LPS of
rhizobacteria, which are phylogenetically related intracellular
plant symbionts, as well as with some human pathogens poorly
related to B. hensleae (e.g. Legionella and Chlamydia), which,
however, share the intracellular life style and the typical
chronic course of infection.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Cultivation—B. henselae ATCC 49882T iso-
lated from the blood of an human immunodeficiency virus-positive
febrile patient was obtained from the Collection de l’Institut Pasteur
(CIP), Paris, France. B. henselae IBS 113 isolated from the blood of a
bacteremic cat was kindly provided by Dr. Y. Piemont, Hopital Louis
Pasteur, University of Strasbourg, Strasbourg, France. B. henselae
ATCC 49882T was grown for 3 days on Columbia agar containing 5%
defibrinated sheep blood at 35 °C in a humidified atmosphere.
Small Scale Isolation of LPS for SDS-PAGE—Bacterial LPS was
isolated from proteinase K-treated whole bacteria, separated by
Tricine-SDS-PAGE and stained by oxidative silver staining as previ-
ously described for Bordetella spp. (17).
Preparative Isolation of LPS—Bacteria were harvested from 500
plates in phosphate-buffered saline and washed twice in distilled water,
followed each time by centrifugation for 30 min at 18,000  g. The
bacterial pellet was finally suspended in a small volume of aqueous
0.5% phenol. Dried bacteria (3.1 g) were washed successively with
ethanol (300 ml), acetone (300 ml), and diethyl ether (300 ml) and dried
in air overnight. The pellet was suspended in water (250 ml), treated
first with RNase and DNase (2 mg each) at stirring over night at room
temperature, then with proteinase K (2 mg) for 24 h at 20 °C, dialyzed
extensively (4 days) against distilled water, and centrifuged. The pre-
cipitate was washed with acetone, suspended in water, and lyophilized
(final yield of washed bacteria: 1.63 g).
Attempts to isolate LPS by direct extraction of the digested dried
bacterial cells described above using the phenol-water (P/W) (18) or
phenol/chloroform/petrol ether procedures (19) were not satisfactory.
After extensive enzyme digestions using proteinase K in the presence of
SDS, mercaptoethanol, and lysozyme, sufficient quantities of B.
henselae LPS for analytical studies could be extracted by the phenol/
chloroform/petrol ether (2:5:8, v/v/v) procedure (19). To remove non-LPS
lipids, prior to extraction cells were washed three times with a 1:1 (v/v)
chloroform/methanol mixture, centrifuged, and dried in a stream of
nitrogen. To remove residual protein from this crude LPS perparation,
the protocol of Hirschfeld et al. (20) was used. An aliquot of the extract
containing 5 mg of LPS gave 2.9 mg of purified LPS, which showed no
banding pattern in SDS-PAGE and Coomassie Brilliant Blue staining.
O-Deacylation of LPS—LPS (14 mg) was dried over P2O5 and treated
with anhydrous hydrazine (0.5 ml) at 37 °C for 35 min at ultrasonica-
tion. Acetone (5 ml) was added in the cold and the precipitate was
separated by centrifugation, washed twice with acetone, dissolved in
water (3 ml), and lyophilized. The product was treated with anhydrous
hydrazine at 37 °C for 1.5 h and treated as above to give O-deacylated
LPS (11 mg).
Alkaline Degradation of LPS—O-Deacylated LPS (11 mg) was heated
with 4 M KOH (1 ml) at 120 °C for 23.5 h, and the reaction mixture was
diluted with water (5 ml), neutralized at 0 °C with 2 M HCl (2 ml), and
extracted with chloroform (2  4 ml). After separation of phases the
precipitate was washed with water (2  2 ml), the combined water
phase and washings were lyophilized. The product was desalted by gel
chromatography on Sephadex G-50 in pyridinium acetate buffer, pH 4.5
(4 ml of pyridine and 10 ml of HOAc in 1 liter of water), and fractionated
by HPAEC using a Dionex system with pulsed amperometric detection
on an analytical CarboPac PA1 column (250  4.6 mm) in a linear
gradient of 0.153 0.5 M NaOAc in 0.1 M NaOH for 70 min at 1 ml/min.
1-ml fractions were collected and analyzed by HPAEC using the same
gradient for 30 min at 1 ml/min. Four products with retention times
19.25, 21.35, 24.75 (major, 300 g), and 28.10 min in the analytical run
were isolated and desalted on a column (40  2.5 cm) of Sephadex G-50
in pyridinium acetate buffer, pH 4.5.
Mild Acid Degradation of LPS—LPS (0.4 mg) was hydrolyzed with
0.1 M sodium acetate buffer, pH 4.4, at 100 °C for 2 h, and the super-
natant was deionized with an IR-120 (H-form) cation-exchange resin
and analyzed by HPAEC in a linear gradient of 0.013 0.08 M NaOAc in
0.1 M NaOH for 30 min at 1 ml/min, which showed the presence of two
compounds with retention times of 23.38 and 24.55 min.
Composition Analyses—For analysis of Kdo, LPS was methanolyzed
with 0.5 M HCl in methanol at 85 °C for 45 min. After removal of the
solvent, the products were peracetylated with Ac2O in pyridine (1:1.5,
v/v, 85 °C, 20 min). For analysis of Glc and GlcN3N, LPS was meth-
anolyzed with 2 M HCl in methanol at 85 °C for 16 h, then hydrolyzed
with 4 M CF3CO2H at 100 °C for 2 h, conventionally borohydride-
reduced and peracetylated (21). For fatty acid analysis, LPS was meth-
anolyzed with 2 M HCl in methanol at 85 °C for 20 h, and sugars were
trimethylsilylated with N,O-bis(trimethylsilyl)trifluoroacetamide (22).
The sugar and fatty acid derivatives were analyzed by GLC on a
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Hewlett-Packard HP 5890 Series II chromatograph, equipped with a
30-m fused silica SPB-5 column (Supelco) using a temperature gradient
of 150 °C (3 min)3 320 °C at 5°/min, and GLC-MS on a Hewlett-
Packard HP 5989A instrument equipped with a 30-m HP-5MS column
(Hewlett-Packard) under the same chromatographic conditions as in
GLC.
Methylation Analysis—O-Deacylated LPS was dephosphorylated
with aqueous 48% hydrofluoric acid (4 °C, 16 h), methylated with CH3I
in dimethyl sulfoxide in the presence of solid NaOH (23), and hydro-
lyzed with 2 M CF3CO2H (100 °C, 2 h). The partially methylated mon-
osaccharides were borohydride-reduced, and Kdo was converted into
the methyl ester by evaporation with 0.5 M HCl in methanol, peracety-
lated, borohydride reduced, peracetylated, and analyzed by GLC and
GLC-MS as described above.
Mass Spectrometry—MALDI-TOF MS was performed on a Bruker-
Reflex II instrument (Bruker-Franzen Analytik, Bremen, Germany) in
linear configuration in the negative mode at an acceleration voltage of
20 kV and delayed ion extraction. Samples were dissolved in chloroform
at a concentration of 5 g/l, and 2 l of solution was mixed with 2 l
of 0.5 M 2,4,6-trihydroxyacetophenone (Aldrich) in methanol as matrix
solution. 1-l aliquots were deposited on a metallic sample holder and
analyzed immediately after drying in a stream of air.
ESI FT-ICR MS/MS was performed using a Fourier transform ion
cyclotron resonance mass analyzer (ApexII, Bruker Daltonics) equipped
with a 7-tesla actively shielded magnet and an Apollo electrospray ion
source. Samples were dissolved in a 30:30:0.01 (v/v/v) mixture of 2-pro-
panol, water, and triethylamine at a concentration of 20 ng/l and
sprayed with a flow rate of 2 l/min. For IRMPD MS/MS, a 40-watt CO2
laser (Synrad Inc., Mukilteo, WA) operating at   10.6 m was used.
Laser power was set to 50% of maximal value. Duration of irradiation
was controlled via the XMASS software (Bruker Daltonics) for optimal
fragmentation (typically 50 ms).
NMR Spectroscopy—Prior to the measurements, the samples were
lyophilized twice from 2H2O. The
1H and 31P NMR spectra were re-
corded with a Bruker DRX-600 spectrometer (Bruker, Rheinstetten,
Germany) at 600 and 243 MHz, respectively, at 27 °C in 99.96% 2H2O.
Chemical shifts were referenced to internal sodium 3-trimethylsilylpro-
panoate-d4 (H 0) and external aqueous 85% H3PO4 (P 0). Bruker
software XWINNMR 2.5 was used to acquire and process the data. A
mixing time of 100 and 200 ms was used in two-dimensional TOCSY
and ROESY experiments, respectively.
Activation of HEK/HEK-CD14 Cells—For transient transfection,
HEK293 cells were plated at a density of 5104/ml in 96-well plates in
Dulbecocc’s modified Eagle’s medium without G418. The following day,
cells were transfected using Polyfect (Qiagen) according to the manu-
facturer’s protocol. Expression plasmid containing human CD14 was a
kind gift of Dr. D. T. Golenbock, Worcester, MA, and the FLAG-tagged
versions of human TLR2 and human TLR4 were a kind gift from P.
Nelson, Seattle, WA and subcloned into pREP9 (Invitrogen). The hu-
man MD-2 expression plasmid was a kind gift from K. Miyake, Tokyo,
Japan. TLR2 and TLR4 plasmids were used at 200 ng/transfection,
CD14 and MD-2 plasmids were used at 25 ng/transfection. The total
DNA content was kept constant at 250 ng/transfection using pCDNA3
(Invitrogen). After 24 h of transfection, cells were washed and stimu-
lated with LPS for another 18 h. Finally, supernatants were collected
and the interleukin-8 content was quantified using a commercial en-
zyme-linked immunosorbent assay (BIOSOURCE).
Bacterial lipopeptide (Pam3CysSK4) was obtained from EMC micro-
collections, Tu¨bingen, Germany, and LPS from S. enterica sv. Friede-
nau was kindly provided by H. Brade, Borstel, Germany.
RESULTS
Purification of B. henselae LPS and Analysis by SDS-
PAGE—Crude LPS extracts from B. henselae isolated following
proteinase K treatment of whole cells was separated by SDS-
PAGE and visualized by silver staining. Consistent with
a recent study examining the LPS composition of several
B. henselae strains (12), we observed for strains ATCC 49882T
(Fig. 1A, lane 1) and IBS 113 (lane 2) the presence of at least
two LPS species of different electrophoretic mobility, an R-form
of about 3 kDa as the major constituent and at least one S-form
of 20 kDa as a minor constituent. LPS was then isolated in
preparative scale from cells of B. henselae ATCC 49882T by
phenol/chloroform/petrol ether extraction (19) following exten-
sive digestion of bacterial cells with proteolytic enzymes. Ex-
traction with chloroform/methanol was necessary to remove
non-LPS lipids. When this purified LPS was tested, no high
molecular mass S-form LPS was observed (Fig. 1B, lane 1),
indicating selective enrichment of the R-form during phenol/
chloroform/petrol ether extraction. The mobility of the R-form
LPS was in the range between that of E. coli deep-rough mu-
tant strain F515 (chemotype Re, containing two Kdo residues
as the core oligosaccharide; Fig. 1B, lane 2) and S. enterica sv.
Minnesota rough mutant R7 (chemotype Rd1, containing two
Kdo and two heptose residues; Fig. 1B, lane 3). Therefore,
B. henselae ATCC 49882T produces a short-chain R-form LPS
with a core ranged in size between di- and tetrasaccharide.
Chemical and Mass Spectrometric Characteriztaion of LPS—
Sugar analysis of the purified LPS showed the presence of Glc,
Kdo, and GlcN3N, but no GlcN. Most likely, Glc and Kdo are
components of the core oligosaccharide portion of LPS, whereas
GlcN3N has been previously identified in the lipid A backbone
of several bacteria (24). Fatty acid analysis revealed 12:0(3-
OH), 16:0(3-OH), 26:0(25-OH), and 28:0(27-OH) as the major
constituents, together with 12:1(3-OH), 14:0(3-OH), 18:0(3-OH)
as minor constituents, and a negligible amount of 18:1(3-OH).
Methylation analysis of the O-deacylated dephosphorylated
LPS, including carboxyl reduction of Kdo, demonstrated 4,5-
disubstituted Kdo (KdoI), terminal Glc, and terminal Kdo
(KdoII). These data indicated that the LPS core is a branched
trisaccharide composed of one Glc and two Kdo residues. A
minor amount of a 5-substituted Kdo residue was also detected,
which, most likely, resulted from a partial elimination of the
terminal Kdo residue in the course of dephosphorylation of LPS
under acidic conditions (25).
The charge-deconvoluted negative ion ESI FT-ICR mass
spectrum of LPS (Fig. 2) showed two major molecular ion peaks
at m/z 2399.44 (MI) and 2427.45 (MII) and a minor peak at m/z
2455.50. Taking into account the composition of LPS, the major
peaks could be assigned to LPS species containing a GlcKdo2
trisaccharide and a bisphosphoryl di-GlcN3N lipid A backbone
acylated with two residues each of 12:0(3-OH) and 16:0(3-OH)
and one residue of either 26:0(25-OH) or 28:0(27-OH). The
minor compound may differ in the replacement of one 12:0(3-
OH) or 16:0(3-OH) residue with a residue of 14:0(3-OH) or
18:0(3-OH), respectively. Furthermore, the spectrum exhibited
minor peaks representing compounds missing one phosphate
group (m/z 2319.47, 2347.50, and 2365.51) or those containing
one unsaturated fatty acid (m/z 2397.43, 2425.45, and 2453.50).
Unlabelled peaks in Fig. 2 represent sodium adduct ions.
Positive ion ESI FT-ICR IRMPD MS/MS of triethylammo-
FIG. 1. Silver-stained SDS-PAGE (20%). A, small scale isolation of
LPS from B. henselae ATCC 49882T (lane 1) and strain IBS 113 (lane 2).
B, purified LPS from B. henselae ATCC 49882T (lane 1), E. coli mutant
F515 (chemotype Re, lane 2), and S. enterica sv. Minnesota mutant R7
(chemotype Rd1, lane 3).
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nium salt of LPS was performed using the molecular ion at m/z
at 2501.41 (MI-salt) as the parent ion (Fig. 3). The spectrum
showed ion peaks due to subsequent loss of triethylammonium
phosphate (m/z 2302.45) and Kdo (m/z 2082.40) or the GlcKdo2
trisaccharide (m/z 1700.28, lipid A ion). The monophosphoryl
lipid A ion was further cleaved to give - and -fragment ions
(according to the nomenclature of Domon and Costello) at m/z
1087.80 and an ion from the reducing end at m/z 613.48
(711.48, P), respectively. This fragmentation pattern showed
that each GlN3N residue in lipid A bears one 12:0(3-OH), one
16:0(3-OH), and one phosphate group and that in MI the 26:
0(25-OH) residue is attached to the non-reducing GlcN3N res-
idue (GlcN3NII).
Alkaline Degradation of LPS and Structure of the Carbohy-
drate Core-Lipid A Backbone—LPS was O-deacylated with an-
hydrous hydrazine. As expected, the negative ion ESI FT-ICR
mass spectrum of the O-deacylated LPS showed ion peaks at
m/z 2005.04 (major) and 2033.08 (minor) for LPS species with
four N-linked fatty acids. Further N-deacylation of the O-deac-
ylated LPS resulted in a mixture of four oligosaccharide
bisphosphates, which were separated by HPAEC. In negative
ion ESI FT-ICR MS/MS, the major compound (1) with the
HPAEC retention time 24.75 min showed a molecular ion peak
at m/z 1099.28 and thus has the full core trisaccharide. The
other compounds have a truncated core lacking either KdoII or
Glc or both KdoII and Glc (molecular ions at m/z 879.22, 937.22,
and 717.17, respectively) (data not shown). The content of the
KdoII-lacking product with the retention time 19.25 min was
twice as low as that of the major compound, whereas the two
Glc-lacking products were present in negligible amounts. Since
no compound with a truncated core was detected in MS studies
on the whole LPS, the minor compounds resulted from partial
cleavage of the glycosidic linkages under strong alkaline
conditions.
Compound 1 was studied by high-field NMR spectroscopy.
The 1H NMR spectrum of compound 1 (Fig. 4) showed signals
for three anomeric protons at  4.32, 5.22, and 5.26, protons at
nitrogen-bearing carbons (H-2 and H-3) of two GlcN3N resi-
dues at  2.48, 2.55, 2.61, and 2.82, and methylene groups of
two Kdo residues at  1.72, 1.92 (both H-3ax), 2.02, and 2.05
(both H-3eq). The spectrum was completely assigned using
two-dimensional 1H,1H COSY, TOCSY, and 1H,13C HMQC ex-
FIG. 3. Positive ion ESI FT-ICR IRMPD MS/MS of triethylammonium salt of LPS of B. henselae ATCC 49882T. The molecular ion at
m/z 2501.41 was used as the parent ion.
FIG. 2. Charge-deconvoluted negative ion FT-ICR ESI mass spectrum of LPS of B. henselae ATCC 49882T.
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periments, and spin systems of one Glc, two GlcN3N, and two
Kdo residues were identified. The 1H and 13C NMR chemical
shifts (Tables I and II) and typical coupling constant values
indicated that all sugar residues are in the pyranose form. A
large J1,2 coupling constant of 8.0 Hz for the H-1 signal at 
4.32 showed that one of the GlcN3N residues (GlcN3NII) is
-linked, whereas Glc and GlcN3NI are -linked (J1,2 3.5 and
3.3 Hz for the H-1 signals at  5.22 and 5.26, respectively). The
H-1 signal of -GlcN3NI was additionally split due to coupling
to phosphorus (J1,P 8.6 Hz). The -configuration of both Kdo
residues followed from the characteristic 1H and 13C NMR
chemical shifts, which were similar to those of -Kdop but
different from the values of -Kdop (26).
A two-dimensional ROESY experiment revealed correlations
of the anomeric proton of GlcN3NII with the protons at the
linkage carbon H-6a,6b of GlcN3NI at  4.32/3.64 (strong) and
 4.32/4.18 (weak), thus indicating the 136-linkage between
the monosaccharides in the lipid A backbone. As expected, no
interresidue cross-peak was observed for H-1 of GlcN3NI at 
5.26. The anomeric proton of Glc showed correlations with H-5
and H-7 of KdoI at  5.22/4.14 (strong) and 5.22/3.94 (weak),
respectively, which are typical of the 135-linkage between
these sugar residues (27). Finally, a strong correlation between
H-3eq of KdoI and H-6 of KdoII at  2.02/3.64 proved that KdoI
and KdoII are -(234)-interlinked (27, 28).
The glycosylation pattern was further confirmed by the 13C
NMR chemical shift data of the linkage carbons (Table II),
whose signals typically shifted down-field compared with their
positions in the corresponding non-substituted monosaccha-
rides. The displacements were relatively large when the sub-
stituent is an aldopyranose (7–8 ppm for C-5 of KdoI and C-6 of
GlcN3NI caused by glycosylation with Glc and GlcN3NII, re-
spectively) and smaller in case of a ketopyranose substituent
(5 and 2 ppm for C-4 of KdoI and C-6 of GlcN3NII glycosy-
lated with KdoII and KdoI, respectively).
The 31P NMR spectrum of compound 1 contained signals for
two phosphate groups at  4.72 and 4.94. A 1H,31P HMQC
experiment showed correlations of the former with H-1 of
GlcN3NI at P/H 4.72/5.26 and the latter with H-4 of GlcN3N
II
at P/H 4.94/3.45. Therefore, the lipid A disaccharide backbone
is bisphosphorylated at positions 1 and 4, and the compound 1
has the structure shown in Fig. 5.
Mild Acid Degradation and Full Structure of LPS—Hydrol-
ysis of LPS at pH 4.4 cleaved the Kdo linkages, including the
linkage between KdoI and lipid A. As expected, analysis of the
released carbohydrate portion by HPAEC, ESI FT-ICR MS/MS,
and 1H NMR spectroscopy (data not shown) indicated the pres-
ence of two compounds, Kdo and a Glc3 Kdo disaccharide.
MALDI-TOF mass spectrum of lipid A showed the presence of
two major ion peaks at m/z 1798.63 (MLA
I) and 1826.64 (MLA
II)
TABLE I
1H NMR chemical shifts of the compound 1 from LPS of B. henselae ATCC 49882T
Sugar residue H-1H-3ax H-2H-3eq H-3H-4 H-4H-5 H-5H-6 H-6aH-7 H-6bH-8a H-8b
-Glcp-(13 5.22 3.42 3.74 3.46 4.01 3.78 3.78
-KdopII-(23 1.72 2.05 3.90 3.90 3.64 3.96 3.65 3.78
34,5)--KdopI-(23 1.92 2.02 4.02 4.14 3.68 3.94 3.69 3.85
36)--GlpN3N4PII-(13 4.32 2.48 2.61 3.45 3.57 3.34 3.74
36)--GlpN3NI-1-P 5.26 2.55 2.82 3.26 3.99 3.64 4.18
TABLE II
13 NMR chemical shifts of the compound 1 from LPS of B. henselae ATCC 49882T
Chemical shifts were determined from the two-dimensional 1H,13C HMQC spectrum.
Sugar residue -1 -2 -3 -4 -5 -6 -7 -8
-Glcp-(13 100.8 73.5 73.9 70.5 72.9 61.4
-KdopII-(23 36.1 68.0a 68.0a 73.6a 70.4 64.5
34,5)--KdopI-(23 36.0 73.1 75.1 73.3 72.0 64.0
36)--GlpN3N4PII-(13 105.2 57.5 59.6 75.3 77.5 64.7
36)--GlpN3NI-1-P 95.7 56.7 55.0 71.5 72.8 70.8
a Superposition of two non-resolved signals.
FIG. 4. 1H NMR spectrum of the compound 1 isolated from LPS of B. henselae ATCC 49882T by stepwise O- and N-deacylation. For
signal assignment, see Table I.
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in similar amounts. They corresponded to bisphosphorylpen-
taacyl lipid A species containing two residues each of 12:0(3-
OH) and 16:0(3-OH) and one residue of 26:0(25-OH) or 28:0(27-
OH), respectively. These data were in full agreement with the
data obtained on the whole LPS. Minor ion peaks were also
present, which could be assigned to (i) the corresponding tet-
FIG. 6. Proposed structure of two
major LPS species of B. henselae
ATCC 49882T. The position of 12:0(3-OH)
and 16:0(3-OH) within each GlcN3N res-
idue could be interchanged; 26:0(25-OH)
and 28:0(27-OH) (n  26 and 28, respec-
tively) could be attached to either 16:0(3-
OH), as shown, or 12:0(3-OH) on GlcN3NII.
Minor LPS species may differ in the re-
placement of 12:0(3-OH) with 12:1(3-OH)
or 14:0(3-OH) and/or 16:0(3-OH) with 18:
0(3-OH) or 18:1(3-OH).
FIG. 5. Structure of the compound 1
isolated from LPS of B. henselae
ATCC 49882T by stepwise O- and
N-deacylation.
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raacyl species lacking 26:0(25-OH) and 28:0(27-OH) (MLA
I 
394 or MLA
II  422), (ii) the species with longer-chain fatty
acids (MLA  28), e.g. those containing 14:0(3-OH) or 18:0(3-
OH) instead of 12:0(3-OH) or 16:0(3-OH), respectively, and (iii)
monophosphoryl species (MLA 80). No tetraacyl and no mono-
phosphoryl lipid A species could be detected in studies of the
whole LPS, and, hence, they were produced during mild acid
degradation of LPS.
These data together showed that the short-chain LPS of B.
henselae ATCC 49882T has the structure shown in Fig. 6.
TLR2 and TLR4/MD-2-dependent Activity in HEK293 Cells—
Next, we investigated which receptors are involved in the ac-
tivation of cells by LPS from B. henselae and Legionella pneu-
mophila having a similar lipid A structure (32). HEK293 cells
were transiently transfected with CD14 and either TLR2 or
TLR4/MD-2 and stimulated with various LPS preparations. As
shown in Fig. 7, the LPS preparations from S. enterica sv.
Friedenau, L. pneumophila, and B. henselae all showed TLR4
activity, although to a different extent. In comparison to the
standard LPS preparation from S. enterica sv. Friedenau, B.
henselae LPS appears to be at least 1,000-fold less active with
respect to TLR4 activity. L. pneumophila LPS expressed a
slightly higher TLR4 activity, still being 10–100-fold less than
that of S. enterica sv. Friedenau LPS (Fig. 7A).
In contrast to TLR4, TLR2 activity was stimulated only by
the crude LPS extracts from L. pneumophila and B. henselae
but neither by the purified B. henselae LPS nor by that of S.
enterica sv. Friedenau (Fig. 7B). The L. pneumophila LPS
preparation showed strong TLR2 activity already at 10 ng/ml,
which reached at 100 ng/ml a level comparable with the stand-
ard bacterial lipopeptide (Pam3CysSK4) preparation serving as
positive control. The absence of CD14 in TLR2 as well as
TLR4/MD-2 transfected cells reduced the activity of all tested
LPS preparations but did not alter the observed differences in
their activity (data not shown).
DISCUSSION
In this study, we have determined the molecular structure
and biological, i.e. endotoxic activity of the major short-chain
LPS form B. henselae ATCC 49882T. This represents the first
detailed LPS structure analysis of a member of the expanding
genus Bartonella, which currently comprises 19 species of fac-
ultative intracellular pathogens, including eight species asso-
ciated with human diseases (4).
The lipid A backbone of B. henselae ATCC 49882T is com-
posed of a bisphosphorylated GlcN3N disaccharide shared with
only a few bacteria, including Pseudomonas diminuta, Brady-
rhizobium japonicum (29), and L. pneumophila (32). Lipid A of
Campylobacter jejuni, which is thus far the most thoroughly
investigated representative of a GlcN3N-containing lipid A, is
composed predominately of a hybrid GlcN3N-GlcN disaccha-
ride, whereas GlcN3N-GlcN3N is found in minor LPS species
(24). The GlcN3N-containing lipid A of C. jejuni has apparently
similar endotoxic activities as those with the typical GlcN-
containing backbone. Thus, there are so far no indications
that the replacement of GlcN with GlcN3N in the lipid A
backbone of C. jejuni influences its biological and physicochem-
ical behavior (24, 33).
However, recently it has been reported that the LPS or lipid
A from L. pneumophila can bind to and signal via TLR2 (34).
The same TLR2-dependent signaling was observed for Lepto-
spira interrogans LPS (35). As both lipid A’s share an identical
4-P--D-GlcpN3N-(136)--D-GlcpN3N-(13P sugar backbone
(36), we were curious to find out whether this structural fea-
ture might determine TLR2 versus TLR4 specific signaling.
Since the LPS of B. henselae shares the same GlcN3N-GlcN3N-
containing lipid A backbone, we examined whether the LPS of
B. henselae can activate TLR2 signaling to a similar extend as
L. pneumophila and L. interrogans LPS. We found that, in
contrast to L. pneumophila LPS, the purified, protein-free LPS
from B. henselae did not mediate any considerable TLR2 acti-
vation when tested in transiently transfected HEK cells. In
agreement with what is stated above on the C. jejuni LPS, we
thus conclude that the nature of the monosaccharide constitu-
ents in the lipid A backbone (GlcN versus GlcN3N) may not be
critical for the endotoxic activity nor determines this structural
feature TLR2-specific signaling.
The B. henselae lipid A is pentaacylated with each GlcN3N
unit carrying one residue each of 3-hydroxydodecanoic and
3-hydroxyhexadecanoic acid. In addition, the non-reducing
GlcN3N II residue carries one ester-linked long-chain fatty
acid, which is either 25-hydroxypentacosanoic acid (26:0(25-
OH)) or 27-hydroxyheptacosanoic acid (28:0(27-OH)). All Rhi-
zobiaceae (i.e. the plant symbiontic rhizobia) and a few other
Rhizobiales, including intracellular mammalian pathogens
Bartonella and Brucella, examined to date contain a (-1)-
hydroxylated long-chain fatty acids in their lipid A, likely re-
flecting their phylogenetic relationship (11, 29). However, be-
FIG. 7. Purified LPS from B. henselae ATCC 49882T activates
HEK293 cells through TLR-4/MD-2. HEK293 cells were transiently
transfected with CD14 and either TLR4/MD-2 (A) or TLR2 (B) as
described under “Experimental Procedures.” After 24 h, cells were
stimulated with indicated ligands for 18 h. Interleukin-8 content of the
supernatant was analyzed by enzyme-linked immunosorbent assay.
One representative experiment out of three is shown.
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cause of a limited number of detailed structural studies on lipid
A’s from these organisms, and because of difficulties associated
with analyzing the long-chain fatty acids, the location, stoichi-
ometry, and type of attachment of these substituents is known
only for a few species, including Sinorhizobium sp. NGR234
and R. etli-R. leguminosarum (30, 31). Interestingly, LPS of the
unrelated intracellular pathogen L. pneumophila appears to
have a related structure too (32) with similar long-chain fatty
acids. However, L. pneumophila lipid A differs in the (-1)-
substituent, which is either 28:0(27-keto) or 27:0(dioic) acid. In
addition, L. pneumophila and B. henselae differ in the degree of
lipid A acylation, B. henselae having a pentaacyl lipid A and
L. pneumophila a hexaacyl lipid A (32).
These common structural features of LPS found among in-
tracellular plant symbionts (i.e. the bacteroids of rhizobia) and
intracellular mammalian pathogens B. henselae and L. pneu-
mophila are expected to have implications for their biological
activity. It is well known that enterobacterial lipid A with a
reduced number of fatty acids, such as a pentaacyl lipid A
lacking a secondary myristic acid (14:0) residue in waaN-mu-
tant of S. enterica sv. Typhimurium, expresses significantly
lower endotoxic activities in mouse peritoneal model (38).
These in vivo data are in full agreement with previous results
showing that the acylation pattern significantly influences the
endotoxic activity in macrophages in various in vitro test sys-
tems (24, 33). In addition, it was postulated (32, 37) that
long-chain fatty acids, as they are present in L. pneumophila,
might be responsible for the failure to interact with CD14 and
TLR4 (37). B. henselae lipid A possesses both features known to
reduce endotoxicity, including a pentaacyl lipid A and a long-
chain fatty acid. Consequently, it showed an at least 1,000-fold
lower activity for signaling via TLR4 as compared with LPS
from enteric bacteria, e.g. that from S. enterica sv. Friedenau.
Similar to enterobacterial LPS, TLR4-mediated signaling by
B. henselae LPS is CD14-dependent. It remains to be demon-
strated whether the low endotoxic activity of B. henselae LPS
results from a diminished interaction with CD14, with TLR4 or
with both receptors.
In contrast to the TLR2 activity of L. pneumophila LPS (34),
we could almost completely eliminate the TLR2 activity of
B. henselae LPS upon further purification, especially with re-
duction of contaminating protein. The reason for the different
TLR-specificity of the structurally related LPS from L. pneu-
mophila and B. henselae remains elusive. As outlined above,
the only difference in lipid A’s of the two bacteria lies in the
nature and number of fatty acids. In L. pneumophila, the main
lipid A species carries six acyl groups, including iso- and dihy-
droxy-atty acids (e.g. i14:0(2,3-diOH)) and 28:0(27-keto) or 27:
0(dioic) long-chain fatty acids (32). In contrast, B. henselae lipid
A carries five acyl groups, no iso- and dihydroxy fatty acids, and
26:0(25-OH) or 28:0(27-OH) long-chain fatty acids. The impor-
tance of the number and the nature of acyl residues with
respect to TLR2 and TLR4 signaling specificity is further sup-
ported with an example of lipid A’s from Porphyromonas gin-
givalis (39) and L. interrogans (35, 36), which do not share any
special structural relationship to each other in their acylation
pattern. However, like L. pneumophila, they express TLR2--
dependent rather than TLR4-dependent activity. Since
B. henselae has a pentaacyl lipid A these data indicate that
neither the structure of the lipid A backbone nor the degree of
phosphorylation or acylation are sufficient to determine TLR2-
and TLR4-specific activity. However, the fatty acid composition
(i.e. the presence of hydroxy, olefinic, keto, and dihydroxy
groups) represent distinct structural motifs of these lipid A and
may thus contribute to determining TLR2 versus TLR4
specificity.
The carbohydrate portion of B. henselae rough-type LPS was
found to consist of a branched trisaccharide, containing a glu-
cose residue attached at position 5 of an -(234)-linked Kdo
disaccharide. A terminal Glc and the absence of L-glycero-d-
manno-heptose and mannose (Man) (40) are remarkable features
of this short-chain LPS core. While carbohydrate structures of a
similar size are typically present in LPS of deep-rough mutants
of bacteria otherwise containing O-polysaccharide chains, all iso-
lates of the obligate intracellular pathogen C. trachomatis inves-
tigated so far contain an unbranched Kdo trisaccharide (41).
Given the obligate intracellular life style of C. trachomatis, the
short-chain carbohydrate moiety of LPS might help adaptation of
the bacterium to intracellular life. The R-form LPS of the facul-
tative intracellular pathogen B. henselae does not seem to result
from a deep-rough mutation as at least one minor S-form LPS
species is simultaneously produced in ATCC 49882T and all other
tested isolates (12). Heterogeneity of LPS in regard to the pres-
ence of an O-chain has previously been reported for the closely
related species B. bacilliformis (14) and B. quintana,2 as well as
for some other rhizobacteria, including the plant symbionts Bra-
dyrhizobium japonicum (28) and Sinorhizobium sp. NGR234
(31), and may be a typical feature of the Rhizobiales. Interest-
ingly, synthesis of the LPS O-chain in Sinorhizobium sp.
NGR234 is regulated differently in the free-living versus endo-
symbiotic state (31), suggesting that the relative proportion of
R-form to S-form LPS species may be a critical factor for the
facultative intracellular life style of this plant symbiont. In future
it will be interesting to recognize whether the facultative intra-
cellular pathogen B. henselae can regulate synthesis of different
amounts of R-form versus S-form LPS species in response to
environmental signals as a specific adaptation to the host.
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